*IAG CONFIRMS IT SUBMITTED A PROPOSAL FOR AER LINGUS
Italy PM Renzi: Not supportive of the new sanctions being evaluated for Russia
International Consolidated Airlines Group, the parent company of British Airways and Iberia, is weighing a takeover offer for Irish carrier Aer Lingus, according to people familiar with the situation.
Any deal will require the backing of Ryanair, which a 29.9 per cent stake in the company and the Irish government. It owns a 25 per cent holding, write Jane Wild, Arash Massoudi and Neil Hume
After a turbulent start to the year, Aer Lingus has seen its fortunes improve. Last month it increased its profit forecast for the full year after a rise in the number of passengers taking long-distance trips as Ireland's economy returned to health.
For IAG a deal would give it a significant increase in valuable take-off and landing slots.
Shares in Aer Lingus were up almost 9 per cent at EURO 1.97 in afternoon trading.
*IAG SAID CONSIDERING TAKEOVER OFFER FOR AER LINGUS: FT
2014-12-18 14:17:08.930 GMT
--CAROLINE SCHABERG
-0- Dec/18/2014 14:17 GMT
2014-12-18 14:17:08.930 GMT
--CAROLINE SCHABERG
-0- Dec/18/2014 14:17 GMT
Greece opposition Syriza party leader Tsipras: Rules out cooperating with ruling parties in current scenario; would seek a wider consensus after national elections
- Reiterates view that if elected the Syriza party would cancel austerity through Parliament and renegotiate debt
Gapping down
In reaction to disappointing earnings/guidance: SIMG -30.3%, MLHR -6%, DNKN -5.8%, WGO -4.2%, WOR -3.4%, ATU -2.5%, HNT -1.8%, CCE -0.8%
Other news: GNW -6.6% (announced it is still in the process of completing its annual review of long term care insurance active life margins), ELLI -5.4% (announced that mortgage refinancing volume rose 5% in November, the fourth straight month of increases, as mortgage interest rates continued to fall), NVGN -5.1% (follow on weakness attributed to offering), NBG -4.5% (still checking), AHS -2.3% (announced a definitive agreement to acquire Onward Healthcare, Locum Leaders, and Medefis from OGH, for a total purchase price of $82.5 mln), BCRX -1.1% (unfavorable commentary on Wednesday's Mad Money)
Analyst comments: XL -2.1% (downgraded to Underperform from Mkt Perform at Bernstein ), AMD -1.0% (initiated with a Sell at Citigroup), FMS -1.0% (downgraded to Neutral at Bryan Garnier)
In reaction to disappointing earnings/guidance: SIMG -30.3%, MLHR -6%, DNKN -5.8%, WGO -4.2%, WOR -3.4%, ATU -2.5%, HNT -1.8%, CCE -0.8%
Other news: GNW -6.6% (announced it is still in the process of completing its annual review of long term care insurance active life margins), ELLI -5.4% (announced that mortgage refinancing volume rose 5% in November, the fourth straight month of increases, as mortgage interest rates continued to fall), NVGN -5.1% (follow on weakness attributed to offering), NBG -4.5% (still checking), AHS -2.3% (announced a definitive agreement to acquire Onward Healthcare, Locum Leaders, and Medefis from OGH, for a total purchase price of $82.5 mln), BCRX -1.1% (unfavorable commentary on Wednesday's Mad Money)
Analyst comments: XL -2.1% (downgraded to Underperform from Mkt Perform at Bernstein ), AMD -1.0% (initiated with a Sell at Citigroup), FMS -1.0% (downgraded to Neutral at Bryan Garnier)
Gapping up
Briefing note: With S&P futures up over 1% this morning, many stocks may be gapping higher that are not idicated below.
In reaction to strong earnings/guidance: ZAGG +20.1%, BIOD +12.8%, RAD +9.9%, AKS +8.3%, JBL +6.1%, ORCL +4.7%, LUB +4.1%, A.CN +2%, APOG +0.9%, STLD +0.9%
M&A news: APP +8.7% (LATimes discusses M&A rumors in APP following news that Charney was suspended as president and CEO), ALU +5.7% (may be in merger talks with Nokia (NOK), according to reports), PTRY +2.2% (to be acquired by Couche-Tard for $36.75/share in cash), MRK +1.7% (announced that it has acquired, through a subsidiary, OncoEthix for upfront payment of $110 mln), NOK +1.1% (may be in merger talks with ALU)
Select metals/mining stocks trading higher: AU +4.8%, CDE +4.6%, IAG +3.3%, ABX +3.2%, KGC +3%, HL +2.4%
Select oil/gas related names showing strength: KEG +18.6%, EXXI +12.7%, MPO +9.4%, PBR +7.8%, PWE +7.8%, PVA +7.3%, LINE +7%, SSL +6.5%, OAS +6.1%, WLL +5.6%, SDRL +4.9%, CHK +3.6%, STO +3.2%, HAL +3%
Other news: MBT +23.6% (Russian related name rebounding), VIP +20.2% (Russian related name rebounding), TTPH +16.3% (announced positive top-line results from Phase 3 IGNITE 1 clinical trial of Eravacycline in complicated intra-abdominal infections), AGEN +9% (announced that its partner GlaxoSmithKline (GSK) reported that the ZOE-50 Phase 3 study met its primary endpoint), CRK +8% (still checking), MPEL +5.8% (disclosed Macau framework agreement), YNDX +4.7% (Russian related name rebounding), HTZ +4.2% (still checking), AGIO +3.4% (favorable commentary on Wednesday's Mad Money), SNE +2.9% (cancels December 25 release of 'The Interview,' according to reports), NAV +2.8% (Carl Icahn disclosed 19.99% active stake in 13D filing), RRD +2.8% (favorable commentary on Wednesday's Mad Money), ONNN +2.5% (announced CMOS operational amplifiers that deliver zero drift operation and quiescent current for front-end amplifier circuits and power mgmt designs), ORAN +2.5% (Funds advised by Apax Partners agree to sell Orange Switzerland to NJJ Capital), WYNN +2.2% (rebounding after recent slide),EXAM +2.1% (to replace OPLK in the S&P SmallCap 600), AMGN +1.5% (increased quarterly dividend 30% to $0.79 from $0.61 per share), CGEN +1.1% (enters Immuno-Oncology research collaboration with Johns Hopkins University), HPQ +1% (favorable commentary on Wednesday's Mad Money), AZN +0.9% (announced that the EC has granted Marketing Authorization for Lynparza as a first-in-class treatment for advanced BRCA-mutated ovarian cancer)
Analyst comments: OVAS +14.2% (released data yday morning; upgraded to Outperform from Neutral at Wedbush), GOL +5.6% (upgraded to Buy from Neutral at BofA/Merrill), BLOX +4.4% (upgraded to Outperform from Sector Perform at Pacific Crest), BHI +2.9% (upgraded to Outperform at RBC Capital Mkts), FDX +1.9% (upgraded to Buy from Neutral at Goldman; tgt $211 -- Added to Conviction Buy List), GLW +1.9% (upgraded to Buy from Neutral at Citigroup), JOY +1.8% (upgraded to Neutral from Underperform at Longbow), LNKD +1.8% (initiated with a Outperform at Wells Fargo), THC +1.7% (initiated with a Buy at Sterne Agee
)
Briefing note: With S&P futures up over 1% this morning, many stocks may be gapping higher that are not idicated below.
In reaction to strong earnings/guidance: ZAGG +20.1%, BIOD +12.8%, RAD +9.9%, AKS +8.3%, JBL +6.1%, ORCL +4.7%, LUB +4.1%, A.CN +2%, APOG +0.9%, STLD +0.9%
M&A news: APP +8.7% (LATimes discusses M&A rumors in APP following news that Charney was suspended as president and CEO), ALU +5.7% (may be in merger talks with Nokia (NOK), according to reports), PTRY +2.2% (to be acquired by Couche-Tard for $36.75/share in cash), MRK +1.7% (announced that it has acquired, through a subsidiary, OncoEthix for upfront payment of $110 mln), NOK +1.1% (may be in merger talks with ALU)
Select metals/mining stocks trading higher: AU +4.8%, CDE +4.6%, IAG +3.3%, ABX +3.2%, KGC +3%, HL +2.4%
Select oil/gas related names showing strength: KEG +18.6%, EXXI +12.7%, MPO +9.4%, PBR +7.8%, PWE +7.8%, PVA +7.3%, LINE +7%, SSL +6.5%, OAS +6.1%, WLL +5.6%, SDRL +4.9%, CHK +3.6%, STO +3.2%, HAL +3%
Other news: MBT +23.6% (Russian related name rebounding), VIP +20.2% (Russian related name rebounding), TTPH +16.3% (announced positive top-line results from Phase 3 IGNITE 1 clinical trial of Eravacycline in complicated intra-abdominal infections), AGEN +9% (announced that its partner GlaxoSmithKline (GSK) reported that the ZOE-50 Phase 3 study met its primary endpoint), CRK +8% (still checking), MPEL +5.8% (disclosed Macau framework agreement), YNDX +4.7% (Russian related name rebounding), HTZ +4.2% (still checking), AGIO +3.4% (favorable commentary on Wednesday's Mad Money), SNE +2.9% (cancels December 25 release of 'The Interview,' according to reports), NAV +2.8% (Carl Icahn disclosed 19.99% active stake in 13D filing), RRD +2.8% (favorable commentary on Wednesday's Mad Money), ONNN +2.5% (announced CMOS operational amplifiers that deliver zero drift operation and quiescent current for front-end amplifier circuits and power mgmt designs), ORAN +2.5% (Funds advised by Apax Partners agree to sell Orange Switzerland to NJJ Capital), WYNN +2.2% (rebounding after recent slide),EXAM +2.1% (to replace OPLK in the S&P SmallCap 600), AMGN +1.5% (increased quarterly dividend 30% to $0.79 from $0.61 per share), CGEN +1.1% (enters Immuno-Oncology research collaboration with Johns Hopkins University), HPQ +1% (favorable commentary on Wednesday's Mad Money), AZN +0.9% (announced that the EC has granted Marketing Authorization for Lynparza as a first-in-class treatment for advanced BRCA-mutated ovarian cancer)
Analyst comments: OVAS +14.2% (released data yday morning; upgraded to Outperform from Neutral at Wedbush), GOL +5.6% (upgraded to Buy from Neutral at BofA/Merrill), BLOX +4.4% (upgraded to Outperform from Sector Perform at Pacific Crest), BHI +2.9% (upgraded to Outperform at RBC Capital Mkts), FDX +1.9% (upgraded to Buy from Neutral at Goldman; tgt $211 -- Added to Conviction Buy List), GLW +1.9% (upgraded to Buy from Neutral at Citigroup), JOY +1.8% (upgraded to Neutral from Underperform at Longbow), LNKD +1.8% (initiated with a Outperform at Wells Fargo), THC +1.7% (initiated with a Buy at Sterne Agee
)
Ex-Wife of TCI’s Hohn Says She Won’t Appeal Divorce Ruling
2014-12-18 13:30:29.193 GMT
By Anthony Aarons
(Bloomberg) -- Jamie Cooper-Hohn, the ex-wife of the
Children’s Investment Fund Management UK LLP founder Chris Hohn,
said she won’t appeal the division of assets in the divorce
case.
* Cooper-Hohn says she still considers the ruling “unjust”
* Cooper-Hohn comments in e-mailed statement
* Hohn was awarded 36.1 percent, or $530 million, of the
couple’s marital assets in divorce case
* NOTE: Ex-Wife of TCI’s Hohn Got 36% of Assets in London
Divorce Case NSN NGHGOD6K50YA<GO>
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Anthony Aarons in London at +44-20-7673-2227 or
aaarons@bloomberg.net
2014-12-18 13:30:29.193 GMT
By Anthony Aarons
(Bloomberg) -- Jamie Cooper-Hohn, the ex-wife of the
Children’s Investment Fund Management UK LLP founder Chris Hohn,
said she won’t appeal the division of assets in the divorce
case.
* Cooper-Hohn says she still considers the ruling “unjust”
* Cooper-Hohn comments in e-mailed statement
* Hohn was awarded 36.1 percent, or $530 million, of the
couple’s marital assets in divorce case
* NOTE: Ex-Wife of TCI’s Hohn Got 36% of Assets in London
Divorce Case NSN NGHGOD6K50YA<GO>
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Anthony Aarons in London at +44-20-7673-2227 or
aaarons@bloomberg.net
Announces major international defense project to be postponed - press
